Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kimia Farma Tbk (KAEF) vs Reksa Dana Syariah Mandiri ETF Emas (XMES) Price & Performance

Kimia Farma TbkTrade
Reksa Dana Syariah Mandiri ETF EmasTrade

Price performance (Past 24H)

Key statistics

Kimia Farma Tbk vs Reksa Dana Syariah Mandiri ETF Emas — how do they compare? Kimia Farma Tbk trades at Rp452 (market cap 2.52T, 1.17M 24h volume), while Reksa Dana Syariah Mandiri ETF Emas trades at Rp793 (market cap 13.37B, 335.6K 24h volume). The key difference: Kimia Farma Tbk is far larger — about 188.5× Reksa Dana Syariah Mandiri ETF Emas's market cap, and Kimia Farma Tbk is more actively traded (1.17M versus 335.6K). Which is the better fit depends on your goals.

KAEFXMES
Market Cap
2.52T13.37B
Volume
1.17M335.6K
Lot
11.68K3.36K
Turnover
528.04M265.66M
Average Price
452.05791.59
Value
528.04M265.66M
Indicative Equilibrium Price
452793
Indicative Equilibrium Volume
4238

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KAEF
View details

About Kimia Farma Tbk

PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.

Read more on KAEF

About Reksa Dana Syariah Mandiri ETF Emas

Read more on XMES